The study excluded patients in cardiogenic shock, acute myocardial infarction (MI), low estimated glomerular filtration rate (eGFR) below 20 ml/min/1.73 m2, major cardiac surgery, type I DM, and current or prior treatment with SGLT1 or SGLT2 inhibitors in the 90 days prior to enrolment. Here, SLC5A2 is linked to myocardial infarction.